Document is current
Any future updates will be listed below
-
Authors
Pratt-Chavez, Heather
Rishel Brakey, Heidi
Sanders, Sarah G.
Patel, Juhee
Ozechowski, Tim
Stoffel, Chloe
Sussman, Andrew L.
Marquez, Jessie
Smith, David R.
Kong, Alberta S.
-
Funding
Funding for this research was provided by:
National Institutes of Health (1R41DA050408-01, 1R41DA050408-01, 1R41DA050408-01, 1R41DA050408-01, 1R41DA050408-01, 1R41DA050408-01)
University of New Mexico Clinical & Translational Science Center (UL1TR001449)
UNM Pediatric Clinical Trials Center in IDeA States Pediatric Clinical Trials Network Office of the Director, NIH (UG1OD024947)
- License Information
-
More Information
Article History
Received: 30 January 2023
Accepted: 13 March 2024
First Online: 19 April 2024
Declarations
:
: Pre- and post-survey data was collected under Exempt Category 2 Protocol 18–270, NOWS-NM Training Initiative - Optimizing care for Neonates at risk for Opiate Withdrawal Syndrome, approved by the University of New Mexico Health Sciences Office of Research Human Research Protections Program Human Research Review Committee (UNM HRRC). Qualitative data was collected under Exempt Category 2 Protocol 19–468, A Mobile/Web-based Training Curriculum for Disseminating Best Practices for the Care of Newborns with Neonatal Opioid Withdrawal Syndrome, approved by the UNM HRRC. Under both protocols, all methods were carried out in accordance with relevant guidelines and regulations. Informed consent was obtained from all subjects (no subjects under the age of 18 were included).
: Not applicable.
: The authors declare no competing interests.
